81 related articles for article (PubMed ID: 10652187)
1. Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction.
Omura T; Yoshiyama M; Takeuchi K; Kim S; Iwao H; Yamagishi H; Toda I; Teragaki M; Akioka K; Yoshikawa J
J Mol Cell Cardiol; 2000 Jan; 32(1):23-33. PubMed ID: 10652187
[TBL] [Abstract][Full Text] [Related]
2. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.
Yoshiyama M; Omura T; Takeuchi K; Kim S; Shimada K; Yamagishi H; Teragaki M; Akioka K; Iwao H; Yoshikawa J
J Mol Cell Cardiol; 2001 Apr; 33(4):799-810. PubMed ID: 11273732
[TBL] [Abstract][Full Text] [Related]
4. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
McWhinney CD; Hunt RA; Conrad KM; Dostal DE; Baker KM
J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
[TBL] [Abstract][Full Text] [Related]
5. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Nio Y; Matsubara H; Murasawa S; Kanasaki M; Inada M
J Clin Invest; 1995 Jan; 95(1):46-54. PubMed ID: 7814645
[TBL] [Abstract][Full Text] [Related]
6. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.
Yamagishi H; Kim S; Nishikimi T; Takeuchi K; Takeda T
J Mol Cell Cardiol; 1993 Nov; 25(11):1369-80. PubMed ID: 8301670
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Tone E; Kunisada K; Fujio Y; Matsui H; Negoro S; Oh H; Kishimoto T; Yamauchi-Takihara K
Biochem Biophys Res Commun; 1998 Dec; 253(1):147-50. PubMed ID: 9875235
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
Hanatani A; Yoshiyama M; Takeuchi K; Kim S; Nakayama K; Omura T; Iwao H; Yoshikawa J
Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Kusuyama T; Yoshiyama M; Omura T; Nishiya D; Enomoto S; Matsumoto R; Izumi Y; Akioka K; Takeuchi K; Iwao H; Yoshikawa J
J Pharmacol Sci; 2005 Jul; 98(3):283-9. PubMed ID: 15997171
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril.
Zhang W; Chen X; Shi S; Wei R; Wang J; Yamanaka N; Hong Q
Nephrol Dial Transplant; 2005 May; 20(5):892-901. PubMed ID: 15755760
[TBL] [Abstract][Full Text] [Related]
13. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats.
Suzuki S; Tanaka K; Nogawa S; Dembo T; Kosakai A; Fukuuchi Y
Exp Neurol; 2001 Jul; 170(1):63-71. PubMed ID: 11421584
[TBL] [Abstract][Full Text] [Related]
15. Cardioplegia and angiotensin II receptor antagonists modulate signal transducers and activators of transcription activation in neonatal rat myocytes.
Lucchese G; Cambi GE; De Rita F; Faggian G; Mazzucco A; Modesti PA; Luciani GB
Artif Organs; 2011 Nov; 35(11):1075-81. PubMed ID: 22097982
[TBL] [Abstract][Full Text] [Related]
16. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Kodama H; Fukuda K; Pan J; Makino S; Sano M; Takahashi T; Hori S; Ogawa S
Circ Res; 1998 Feb; 82(2):244-50. PubMed ID: 9468195
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation.
Takahashi M; Tanonaka K; Yoshida H; Koshimizu M; Oikawa R; Daicho T; Takeo S
Eur J Pharmacol; 2005 Oct; 522(1-3):84-93. PubMed ID: 16185685
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein.
Bhat GJ; Thekkumkara TJ; Thomas WG; Conrad KM; Baker KM
J Biol Chem; 1994 Dec; 269(50):31443-9. PubMed ID: 7527386
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
El-Sabban ME; Hassan KA; Birbari AE; Bitar KM; Bikhazi AB
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):369-78. PubMed ID: 11967826
[TBL] [Abstract][Full Text] [Related]
20. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
